Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jonathan Samuel Vogelgsang, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Besse M, Belz M, Folsche T, Vogelgsang J, Methfessel I, Steinacker P, Otto M, Wiltfang J, Zilles D. Serum neurofilament light chain (NFL) remains unchanged during electroconvulsive therapy. World J Biol Psychiatry. 2020 02; 21(2):148-154. PMID: 31818180.
    Citations:    
  2. Timäus C, Vogelgsang J, Kis B, Radenbach K, Wolff-Menzler C, Mavridou K, Gyßer S, Hessmann P, Wiltfang J. Current clinical practice of electroconvulsive therapy and repetitive transcranial magnetic stimulation in psychiatry, a German sample. Eur Arch Psychiatry Clin Neurosci. 2020 Jan 29. PMID: 31996994.
    Citations:    
  3. Soares Martins T, Magalhães S, Rosa IM, Vogelgsang J, Wiltfang J, Delgadillo I, Catita J, da Cruz E Silva OAB, Nunes A, Henriques AG. Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study. J Alzheimers Dis. 2020; 74(1):391-405. PMID: 32039849.
    Citations:    
  4. Vogelgsang J, Wiltfang J. [New biomarkers for Alzheimer's disease in cerebrospinal fluid and blood]. Nervenarzt. 2019 Sep; 90(9):907-913. PMID: 31407045.
    Citations:    
  5. Teuber-Hanselmann S, Rekowski J, Vogelgsang J, von Arnim C, Reetz K, Stang A, Jöckel KH, Wiltfang J, Esselmann H, Otto M, Tumani H, Herring A, Keyvani K. CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2020 01; 91(1):40-48. PMID: 31371645.
    Citations:    
  6. Hessmann P, Zeidler J, Stahmeyer J, Eberhard S, Vogelgsang J, Abdel-Hamid M, Wolff-Menzler C, Wiltfang J, Kis B. Claims Data Analysis on the Dispensing of Tricyclic Antidepressants Among Patients With Dementia in Germany. Front Pharmacol. 2019; 10:841. PMID: 31396091.
    Citations:    
  7. Vogelgsang J, Kis B, Radenbach K, Wolff-Menzler C, Mavridou K, Timäus C, Gyßer S, Wiltfang J, Hessmann P. Nuclear medical imaging as part of dementia diagnostics in psychiatric day-care clinics and inpatient care settings. Aging Clin Exp Res. 2020 May; 32(5):809-815. PMID: 31286431.
    Citations:    
  8. Vogelgsang J, Heßmann P, Wolff-Menzler C, Gyßer S, Müller GA, Wiltfang J. Prevalence of affective disorders and dementia in inflammatory polyarthropathies. Eur Arch Psychiatry Clin Neurosci. 2020 Mar; 270(2):247-252. PMID: 31025090.
    Citations:    
  9. Santos JRF, Bauer C, Schuchhardt J, Wedekind D, Waniek K, Lachmann I, Wiltfang J, Vogelgsang J. Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease. J Neural Transm (Vienna). 2019 03; 126(3):339-348. PMID: 30767082.
    Citations:    
  10. Bouter C, Vogelgsang J, Wiltfang J. Comparison between amyloid-PET and CSF amyloid-ß biomarkers in a clinical cohort with memory deficits. Clin Chim Acta. 2019 May; 492:62-68. PMID: 30735665.
    Citations:    
  11. Vogelgsang J, Vukovich R, Wedekind D, Wiltfang J. Higher Level of Mismatch in APOEe4 Carriers for Amyloid-Beta Peptide Alzheimer's Disease Biomarkers in Cerebrospinal Fluid. ASN Neuro. 2019 Jan-Dec; 11:1759091419845524. PMID: 31104469.
    Citations:    
  12. Shahpasand-Kroner H, Klafki HW, Bauer C, Schuchhardt J, Hüttenrauch M, Stazi M, Bouter C, Wirths O, Vogelgsang J, Wiltfang J. A two-step immunoassay for the simultaneous assessment of Aß38, Aß40 and Aß42 in human blood plasma supports the Aß42/Aß40 ratio as a promising biomarker candidate of Alzheimer's disease. Alzheimers Res Ther. 2018 12 08; 10(1):121. PMID: 30526652.
    Citations:    
  13. Lewczuk P, Gaignaux A, Kofanova O, Ermann N, Betsou F, Brandner S, Mroczko B, Blennow K, Strapagiel D, Paciotti S, Vogelgsang J, Roehrl MH, Mendoza S, Kornhuber J, Teunissen C. Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer's disease. Alzheimers Res Ther. 2018 08 28; 10(1):87. PMID: 30153863.
    Citations:    
  14. Vogelgsang J, Wolff-Menzler C, Kis B, Abdel-Hamid M, Wiltfang J, Hessmann P. Cardiovascular and metabolic comorbidities in patients with Alzheimer's disease and vascular dementia compared to a psychiatric control cohort. Psychogeriatrics. 2018 Sep; 18(5):393-401. PMID: 29993172.
    Citations:    
  15. Vogelgsang J, Shahpasand-Kroner H, Vogelgsang R, Streit F, Vukovich R, Wiltfang J. Multiplex immunoassay measurement of amyloid-ß42 to amyloid-ß40 ratio in plasma discriminates between dementia due to Alzheimer's disease and dementia not due to Alzheimer's disease. Exp Brain Res. 2018 05; 236(5):1241-1250. PMID: 29480353.
    Citations:    
  16. Vogelgsang J, Wiltfang J, Klafki HW. Validation of a Chemiluminescence Immunoassay for Measuring Amyloid-ß in Human Blood Plasma. Methods Mol Biol. 2018; 1750:111-124. PMID: 29512068.
    Citations:    
  17. Vogelgsang J, Wedekind D, Bouter C, Klafki HW, Wiltfang J. Reproducibility of Alzheimer's Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions. J Alzheimers Dis. 2018; 62(1):203-212. PMID: 29439341.
    Citations:    
  18. Kohl Z, Ben Abdallah N, Vogelgsang J, Tischer L, Deusser J, Amato D, Anderson S, Müller CP, Riess O, Masliah E, Nuber S, Winkler J. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC a-synuclein transgenic rat model of Parkinson's disease. Neurobiol Dis. 2016 Jan; 85:206-217. PMID: 26523794.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Vogelgsang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (68)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.